Remove Chemotherapy Remove Generic Medicine Remove Vaccines
article thumbnail

CHMP meeting highlights – March 2023

European Pharmaceutical Review

It is the eighth vaccine recommended in the European Union (EU) for COVID-19. The committee recommended granting a paediatric-use marketing authorisation (PUMA) for Pedmarqsi (sodium thiosulfate) for preventing ototoxicity induced by cisplatin chemotherapy. Cisplatin is a chemotherapy used to treat several types of cancer.

article thumbnail

CHMP meeting highlights – December 2022

European Pharmaceutical Review

The group adopted a positive opinion for Tremelimumab AstraZeneca (tremelimumab), to treat metastatic non-small cell lung cancer (NSCLC) in combination with Imfinzi (durvalumab) and platinum-based chemotherapy. The committee recommended to extend the use of original Spikevax vaccine and Spikevax bivalent Original/Omicron BA.1